Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

402 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Prediction Rule for Distinguishing Bacterial From Aseptic Meningitis.
Mintegi S, García S, Martín MJ, Durán I, Arana-Arri E, Fernandez CL, Benito J, Hernández-Bou S; Meningitis Group of the Spanish Society of Pediatric Emergencies. Mintegi S, et al. Among authors: duran i. Pediatrics. 2020 Sep;146(3):e20201126. doi: 10.1542/peds.2020-1126. Epub 2020 Aug 25. Pediatrics. 2020. PMID: 32843440 Free article.
Febrile young infants with abnormal urine dipstick at low risk of invasive bacterial infection.
Velasco R, Lejarzegi A, Gomez B, de la Torre M, Duran I, Camara A, de la Rosa D, Manzano S, Rodriguez J, González A, Lopes AA, Rivas A, Martinez I, Angelats CM, Moya S, Corral S, Alonso J, Del Rio P, Sancho E, Ruiz Del Olmo I, Nieto I, Vega B, Mintegi S; Research in European Pediatric Emergency Medicine (REPEM) and the Spanish Pediatric Emergency Research Group (RISeuP-SPERG). Velasco R, et al. Among authors: duran i. Arch Dis Child. 2021 Jul 19;106(8):758-763. doi: 10.1136/archdischild-2020-320468. Arch Dis Child. 2021. PMID: 33246922
Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma.
Talukder R, Bakaloudi DR, Makrakis D, Diamantopoulos LN, Enright T, Leary JB, Raychaudhuri R, Tripathi N, Agarwal N, Jindal T, Brown JR, Zakharia Y, Rey-Cárdenas M, Castellano D, Nguyen CB, Alva A, Zakopoulou R, Bamias A, Barrera RM, Marmolejo D, Drakaki A, Pinato DJ, Korolewicz J, Buznego LA, Duran I, Carballeira CC, McKay RR, Stewart TF, Gupta S, Barata P, Yu EY, Koshkin VS, Khaki AR, Grivas P. Talukder R, et al. Among authors: duran i. Clin Genitourin Cancer. 2024 Dec 2;23(1):102284. doi: 10.1016/j.clgc.2024.102284. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39798390
Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial.
Rosenberg JE, Galsky MD, Powles T, Petrylak DP, Bellmunt J, Loriot Y, Necchi A, Hoffman-Censits J, Perez-Gracia JL, van der Heijden MS, Dreicer R, Durán I, Castellano D, Drakaki A, Retz M, Sridhar SS, Grivas P, Yu EY, O'Donnell PH, Burris HA, Mariathasan S, Shi Y, Goluboff E, Bajorin D. Rosenberg JE, et al. Among authors: duran i. ESMO Open. 2024 Dec;9(12):103972. doi: 10.1016/j.esmoop.2024.103972. Epub 2024 Dec 5. ESMO Open. 2024. PMID: 39642637 Free PMC article. Clinical Trial.
Calorimetry probe for runaway electron heat load measurement at COMPASS.
Caloud J, Tomesova E, Ficker O, Cerovsky J, Mlynar J, Adamek J, Barton P, Bilkova P, Bohm P, Bousek M, Brotankova J, Duran I, Entler S, Havranek A, Jerab M, Kovarik K, Krbec J, Kulkov S, Marcisovsky M, Sos M, Tadros M, Tomes M, Varavin M, Vondracek P, Weinzettl V; COMPASS Team. Caloud J, et al. Among authors: duran i. Rev Sci Instrum. 2024 Nov 1;95(11):113512. doi: 10.1063/5.0222211. Rev Sci Instrum. 2024. PMID: 39601651
Loneliness and social isolation in people with HIV aged ≥50 years. The No One Alone (NOA)-GeSIDA study conducted by the GeSIDA 12021 study group.
Blanco JR, Gonzalez-Baeza A, Martinez-Vicente A, Albendin-Iglesias H, De La Torre J, Jarrin I, González-Cuello I, Cabello-Clotet N, Barrios-Blandino AM, Sanjoaquin-Conde I, Montes-Ramirez ML, Melus E, Pérez-Esquerdo V, Tomas-Jimenez C, Saumoy-Linares M, Lopez-Lirola AM, Hidalgo-Tenorio C, Muelas-Fernandez M, Galindo-Puerto MJ, Abadía J, Manzanares E, Segundo-Martin C, Fernandez-Lopez MA, Barrios-Vega M, De Miguel M, Olalla J; Grupo_Estudio_Gesida_12021. Blanco JR, et al. HIV Med. 2024 Nov 22. doi: 10.1111/hiv.13743. Online ahead of print. HIV Med. 2024. PMID: 39578382
402 results